Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 2 |
2021 | 1 |
2023 | 3 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
Cancers (Basel). 2024 Apr 11;16(8):1465. doi: 10.3390/cancers16081465.
Cancers (Basel). 2024.
PMID: 38672547
Free PMC article.
Fascin-1 expression is associated with neuroendocrine prostate cancer and directly suppressed by androgen receptor.
Turpin A, Delliaux C, Parent P, Chevalier H, Escudero-Iriarte C, Bonardi F, Vanpouille N, Flourens A, Querol J, Carnot A, Leroy X, Herranz N, Lanel T, Villers A, Olivier J, Touzet H, de Launoit Y, Tian TV, Duterque-Coquillaud M.
Turpin A, et al. Among authors: parent p.
Br J Cancer. 2023 Dec;129(12):1903-1914. doi: 10.1038/s41416-023-02449-x. Epub 2023 Oct 24.
Br J Cancer. 2023.
PMID: 37875732
Free PMC article.
Item in Clipboard
Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer.
Parent P, Marcq G, Adeleke S, Turpin A, Boussios S, Rassy E, Penel N.
Parent P, et al.
Ther Adv Med Oncol. 2023 Sep 7;15:17588359231192402. doi: 10.1177/17588359231192402. eCollection 2023.
Ther Adv Med Oncol. 2023.
PMID: 37692364
Free PMC article.
Review.
Item in Clipboard
Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma.
Parent P, Auclin E, Patrikidou A, Mezquita L, Martínez Chanzá N, Dumont C, Rodriguez-Vida A, Llacer C, Lozano R, Ratta R, Merseburger AS, Sternberg CN, Baciarello G, Colomba E, Fuerea A, Besse B, Loriot Y, Lavaud P.
Parent P, et al.
Cancers (Basel). 2023 Feb 7;15(4):1066. doi: 10.3390/cancers15041066.
Cancers (Basel). 2023.
PMID: 36831409
Free PMC article.
Item in Clipboard
Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study.
Epaillard N, Parent P, Loriot Y, Lavaud P, Vera-Cea EB, Martinez-Chanza N, Rodriguez-Vida A, Dumont C, Lozano R, Llácer C, Ratta R, Oudard S, Thibault C, Auclin E.
Epaillard N, et al. Among authors: parent p.
Front Oncol. 2021 May 20;11:671969. doi: 10.3389/fonc.2021.671969. eCollection 2021.
Front Oncol. 2021.
PMID: 34094973
Free PMC article.
Item in Clipboard
A comprehensive overview of promising biomarkers in stage II colorectal cancer.
Parent P, Cohen R, Rassy E, Svrcek M, Taieb J, André T, Turpin A.
Parent P, et al.
Cancer Treat Rev. 2020 Aug;88:102059. doi: 10.1016/j.ctrv.2020.102059. Epub 2020 Jun 23.
Cancer Treat Rev. 2020.
PMID: 32622273
Review.
Item in Clipboard
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
Rassy E, Parent P, Lefort F, Boussios S, Baciarello G, Pavlidis N.
Rassy E, et al. Among authors: parent p.
Crit Rev Oncol Hematol. 2020 Mar;147:102882. doi: 10.1016/j.critrevonc.2020.102882. Epub 2020 Jan 23.
Crit Rev Oncol Hematol. 2020.
PMID: 32106012
Review.
Item in Clipboard
Cite
Cite